Clearside Biomedical Inc (CLSD)
1.28
-0.03
(-2.29%)
USD |
NASDAQ |
May 06, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical Cash from Operations (Quarterly): 0.495M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.495M |
| September 30, 2023 | -6.075M |
| June 30, 2023 | -5.339M |
| March 31, 2023 | -7.216M |
| December 31, 2022 | -5.607M |
| September 30, 2022 | -6.186M |
| June 30, 2022 | -5.443M |
| March 31, 2022 | 3.871M |
| December 31, 2021 | 5.054M |
| September 30, 2021 | -3.278M |
| June 30, 2021 | -6.95M |
| March 31, 2021 | -5.559M |
| December 31, 2020 | -4.436M |
| September 30, 2020 | -2.661M |
| June 30, 2020 | -3.22M |
| March 31, 2020 | -2.803M |
| December 31, 2019 | 1.689M |
| September 30, 2019 | -6.047M |
| Date | Value |
|---|---|
| June 30, 2019 | -10.06M |
| March 31, 2019 | -12.65M |
| December 31, 2018 | -24.26M |
| September 30, 2018 | -19.72M |
| June 30, 2018 | -19.57M |
| March 31, 2018 | -15.65M |
| December 31, 2017 | -15.09M |
| September 30, 2017 | -13.46M |
| June 30, 2017 | -11.55M |
| March 31, 2017 | -10.98M |
| December 31, 2016 | -6.456M |
| September 30, 2016 | -6.374M |
| June 30, 2016 | -5.483M |
| March 31, 2016 | -4.396M |
| December 31, 2015 | -3.829M |
| September 30, 2015 | -3.151M |
| June 30, 2015 | -3.174M |
| March 31, 2015 | -3.748M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.06M
Minimum
Jun 2019
5.054M
Maximum
Dec 2021
-3.672M
Average
-5.339M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Cassava Sciences Inc | -22.32M |
| Heron Therapeutics Inc | 2.455M |
| Actinium Pharmaceuticals Inc | -7.374M |
| Karyopharm Therapeutics Inc | -18.58M |
| Ocular Therapeutix Inc | -22.45M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.12M |
| Cash from Financing (Quarterly) | -0.257M |
| Free Cash Flow | -19.91M |
| Free Cash Flow Per Share (Quarterly) | 0.006 |
| Free Cash Flow to Equity (Quarterly) | 0.375M |
| Free Cash Flow Yield | -25.17% |